
Rabiara-D 30mg/20mg Capsule SR
Marketer
Eiara Pharmaceuticals
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rabiara-D 30mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD) is effectively managed with the dual-action formulation, Rabiara-D 30mg/20mg sustained-release capsules. This medication alleviates common GERD symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. Administer Rabiara-D on an empty stomach, following your physician's prescribed dosage and duration. Treatment adherence is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Always inform your healthcare provider of all other medications you are using, as potential drug interactions exist. Common, typically transient side effects include diarrhea, abdominal discomfort, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects promptly. Due to potential drowsiness and dizziness, refrain from operating machinery or engaging in activities requiring concentration until the medication's effects are known. Alcohol consumption should be avoided to minimize drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, can enhance treatment outcomes. Pre-treatment consultation with your doctor is essential if you have kidney or liver impairment, or if you are pregnant, planning a pregnancy, or breastfeeding.
Primary Ingredients of Rabiara-D 30mg/20mg Capsule SR
No text provided to rephrase.
Uses of Rabiara-D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rabiara-D 30mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Rabiara-D 30mg/20mg Capsule SR whole; do not alter its form by chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Rabiara-D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rabiara-D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the entire capsule without chewing, crushing, or fracturing it. Administer Rabiara-D 30mg/20mg sustained-release capsules on an empty stomach.
How Rabiara-D 30mg/20mg Capsule SR works:
Rabiara-D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, acting synergistically to alleviate digestive discomfort. Domperidone, a gastrointestinal motility stimulant, enhances the transit of food through the upper digestive tract. Rabeprazole, a proton pump inhibitor (PPI), decreases gastric acid secretion, providing relief from acid reflux and indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rabiara-D 30mg/20mg SR Capsules concurrently with alcohol. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The extended-release Rabiara-D 30mg/20mg capsule might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Rabiara-D 30mg/20mg capsule likely poses a safety risk for breastfeeding individuals. Available human data indicate potential transfer to breast milk with the possibility of infant harm.
DrivingUNSAFE
Driving may be unsafe while taking Rabiara-D 30mg/20mg SR capsules, as drowsiness, blurred vision, and dizziness are potential side effects.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Rabiara-D 30mg/20mg sustained-release capsules. Dosage modification of Rabiara-D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when taking Rabiara-D 30mg/20mg SR capsules; dosage modification may be necessary. Physician consultation is advised. Rabiara-D 30mg/20mg SR capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Rabiara-D 30mg/20mg Capsule SR :
Should you forget to take your Rabiara-D 30mg/20mg sustained-release capsule, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Rabiara-D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
